We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXC icon
701
DXC Technology
DXC
$1.92B
$3.65M 0.01%
44,437
-264,252
-86% -$21.3M
LTC
702
LTC Properties
LTC
$2.34B
$3.65M 0.01%
83,686
+213
+0.3% +$9.86K
DBS
703
DELISTED
Invesco DB Silver Fund
DBS
$3.63M 0.01%
139,370
+34,940
+33% +$895K
WSM icon
704
Williams-Sonoma
WSM
$26.1B
$3.62M 0.01%
140,000
+73,000
+109% +$1.86M
KN icon
705
Knowles
KN
$2.97B
$3.62M 0.01%
246,648
+14,700
+6% +$230K
POT
706
DELISTED
Potash Corp Of Saskatchewan
POT
$3.59M 0.01%
173,932
+5,244
+3% +$102K
TOL icon
707
Toll Brothers
TOL
$12.4B
$3.59M 0.01%
+74,782
New +$3.44M
CHRS icon
708
Coherus Oncology
CHRS
$205M
$3.59M 0.01%
407,654
-406
-0.1% -$4.35K
FSTX
709
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.58M 0.01%
66,646
+4,714
+8% +$280K
HBI
710
DELISTED
Hanesbrands
HBI
$3.57M 0.01%
170,656
-131,405
-44% -$2.81M
CAKE icon
711
Cheesecake Factory
CAKE
$4.81B
$3.56M 0.01%
73,800
-69,800
-49% -$3.17M
AXS icon
712
AXIS Capital
AXS
$7.34B
$3.54M 0.01%
+70,356
New +$3.75M
UGI icon
713
UGI
UGI
$8.11B
$3.53M 0.01%
75,200
BHVN
714
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.52M 0.01%
+130,484
New +$3.59M
WEC icon
715
WEC Energy
WEC
$33.7B
$3.5M 0.01%
52,634
-4,200
-7% -$282K
WPS
716
DELISTED
iShares International Developed Property ETF
WPS
$3.45M 0.01%
87,380
-4,300
-5% -$167K
ACWV icon
717
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.36B
$3.44M 0.01%
40,740
-6,440
-14% -$536K
PCAR icon
718
PACCAR
PCAR
$64.5B
$3.44M 0.01%
72,503
BR icon
719
Broadridge
BR
$19.4B
$3.41M 0.01%
37,652
-48
-0.1% -$4.19K
WBT
720
DELISTED
Welbilt, Inc.
WBT
$3.4M 0.01%
144,779
+45,084
+45% +$994K
B
721
Barrick Mining
B
$70.3B
$3.4M 0.01%
234,816
-8,934
-4% -$132K
AGG icon
722
iShares Core US Aggregate Bond ETF
AGG
$137B
$3.39M 0.01%
31,020
+990
+3% +$108K
TCOM icon
723
Trip.com Group
TCOM
$24.7B
$3.38M 0.01%
76,572
+4,372
+6% +$209K
PPLI
724
People Inc
PPLI
$2.85B
$3.37M 0.01%
154,249
-236,870
-61% -$5.3M
VRA icon
725
Vera Bradley
VRA
$116M
$3.36M 0.01%
275,959
+145,800
+112% +$1.32M

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.